Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 242 entries
View as:

Long Term Effects of an Early Response to Certolizumab Pegol (CZP, Cimzia®) in Rheumatoid Arthritis (RA) Patients

Phase: N/A Priority: Normal
NCT ID: NCT01288287 Org: User:
Start: 07/31/11 End: 12/31/14 Due: 12/31/15

Three-way-cross-over Study to Evaluate Safety and Pharmacokinetics of Lacosamide in Healthy Japanese and Chinese Males

Phase: N/A Priority: Normal
NCT ID: NCT01375387 Org: User:
Start: 03/31/11 End: 06/30/11 Due: 06/30/12

Efficacy and Safety of Cetirizine Tablets Versus Ketotifen Dry Syrup in Children With Perennial Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT00639587 Org: User:
Start: 08/31/02 End: 03/31/03 Due: 03/31/04

A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures

Phase: N/A Priority: Normal
NCT ID: NCT00698581 Org: User:
Start: 08/31/08 End: 02/28/10 Due: 02/28/11

Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT00160654 Org: User:
Start: 11/24/03 End: 12/12/06 Due: 12/12/07

Study to Assess the Efficacy and Safety of Levetiracetam for the Treatment of Social Anxiety Disorder (Generalized Type)

Phase: N/A Priority: Normal
NCT ID: NCT00612859 Org: User:
Start: 09/30/03 End: 06/30/04 Due: 06/30/05

Testing the Efficacy of Different Dosages of Lercanidipine to Reduce Hypertensive Blood Pressure in Normal Weight and Obese Patients

Phase: N/A Priority: Normal
NCT ID: NCT00160498 Org: User:
Start: 05/31/04 End: 08/31/05 Due: 08/31/06

A Multicenter, Open-Label, Randomized Crossover Trial to Assess Subject Preference for Alprazolam Orally Disintegrating Tablets Compared to Conventional Alprazolam Tablets in Subjects With Anxiety

Phase: N/A Priority: Normal
NCT ID: NCT00139854 Org: User:
Start: 08/31/04 End: 11/30/04 Due: 11/30/05

Observational Study in Infants Who Are Prescribed Treatment With Keppra® (Levetiracetam) Oral Solution

Phase: N/A Priority: Normal
NCT ID: NCT01210690 Org: User:
Start: 01/31/11 End: 11/30/13 Due: 11/30/14

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Phase: N/A Priority: Normal
NCT ID: NCT01484977 Org: User:
Start: 12/31/11 End: 12/31/13 Due: 12/31/14

An Extension Trial to Investigate Long-Term Treatment With Transdermal Rotigotine in Idiopathic Restless Legs Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00263068 Org: User:
Start: 12/31/05 End: 12/31/07 Due: 12/31/08

Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE)

Phase: N/A Priority: Normal
NCT ID: NCT01093911 Org: User:
Start: 03/31/10 End: 12/31/12 Due: 12/31/13

A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT00621959 Org: User:
Start: 03/31/08 End: 06/30/08 Due: 06/30/09

Study Evaluating the Pharmacokinetics and Safety of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE)

Phase: N/A Priority: Normal
NCT ID: NCT01449071 Org: User:
Start: 10/31/11 End: 03/31/13 Due: 03/31/14

S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT00630968 Org: User:
Start: 08/31/00 End: 02/29/04 Due: 02/28/05

Trial to Assess the Efficacy and Safety of SPM 927 (200, 400, and 600mg/Day) in Subjects With Painful Distal Diabetic Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT00135109 Org: User:
Start: 10/31/04 End: 12/31/05 Due: 12/31/06

A Trial Evaluating Safety of Chronic Therapy With Certolizumab Pegol in Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00358683 Org: User:
Start: 11/30/07 End: - Due: -

Open Label Long-Term Safety Study of Certolizumab Pegol (CZP) for Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00160693 Org: User:
Start: 03/31/03 End: 02/28/11 Due: 02/28/12

Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription

Phase: N/A Priority: Normal
NCT ID: NCT00244465 Org: User:
Start: 05/31/06 End: 09/30/16 Due: 09/30/17

Open Label Trial to Study the Long-term Safety and Efficacy of Seletracetam for the Treatment of Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT00175851 Org: User:
Start: 05/31/08 End: - Due: -

Comparison Bioequivalence Study: Pre-filled Syringe (Reference) Versus Auto-injection Device (Test)

Phase: N/A Priority: Normal
NCT ID: NCT00845663 Org: User:
Start: 10/31/07 End: 04/30/08 Due: 04/30/09

A Trial to Investigate Safety and Efficacy of SPM927 in Painful Diabetic Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT00861445 Org: User:
Start: 06/30/01 End: 02/28/03 Due: 02/28/04

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advance-Stage Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00594386 Org: User:
Start: 08/31/02 End: 12/31/08 Due: 12/31/09

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

Phase: N/A Priority: Normal
NCT ID: NCT01261325 Org: User:
Start: 12/31/10 End: 05/31/14 Due: 05/31/15

A Placebo-controlled Study of Levetiracetam In Children (1mo to 4yrs of Age) With Partial Onset Seizures.

Phase: N/A Priority: Normal
NCT ID: NCT00175890 Org: User:
Start: 10/31/04 End: 01/31/07 Due: 01/31/08